secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bone Biologics Corp (BBLG)
CIK:        0001419554
Form:       8-K
Filed at:   2026-09-16T21:00:39+00:00
Accession:  0001493152-26-042940
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Bone Biologics gets Nasdaq bid-price delisting notice; plans reverse split vote
-------------------------------------------------------------------------------

- Nasdaq notice on Sept 10, 2026: BBLG common stock bid price below $1 for 30 consecutive sessions, violating Rule 5550(a)(2).
- 180-day compliance period runs to March 9, 2027; can cure with 10 straight business days at $1.00 or higher.
- If not cured, may qualify for additional 180-day period if other listing standards met; otherwise delisting proceedings start.
- Company intends to seek stockholder approval for a reverse stock split at upcoming annual meeting to regain compliance.
- Notice has no immediate effect on Nasdaq listing; management monitoring bid price and evaluating options.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1419554/000149315226042940/0001493152-26-042940-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1419554/000149315226042940/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-042940

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer